Ko HJ - Search Results

1

A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model.

Ko HJ, Kim YJ, Kim YS, Chang WS, Ko SY, Chang SY, Sakaguchi S, Kang CY. Ko HJ, et al. Among authors: ko sy. Cancer Res. 2007 Aug 1;67(15):7477-86. doi: 10.1158/0008-5472.CAN-06-4639. Cancer Res. 2007. PMID: 17671218

2

Comparative analysis of effects of cytokine gene adjuvants on DNA vaccination against Mycobacterium tuberculosis heat shock protein 65.

Baek KM, Ko SY, Lee M, Lee JS, Kim JO, Ko HJ, Lee JW, Lee SH, Cho SN, Kang CY. Baek KM, et al. Among authors: ko sy, ko hj. Vaccine. 2003 Sep 8;21(25-26):3684-9. doi: 10.1016/s0264-410x(03)00378-5. Vaccine. 2003. PMID: 12922098

3

Enhanced efficacy of DNA vaccination against Her-2/neu tumor antigen by genetic adjuvants.

Chang SY, Lee KC, Ko SY, Ko HJ, Kang CY. Chang SY, et al. Among authors: ko sy, ko hj. Int J Cancer. 2004 Aug 10;111(1):86-95. doi: 10.1002/ijc.20232. Int J Cancer. 2004. PMID: 15185348

4

Heparan sulfate regulates the antiangiogenic activity of endothelial monocyte-activating polypeptide-II at acidic pH.

Chang SY, Ko HJ, Heo TH, Kang CY. Chang SY, et al. Among authors: ko hj. Mol Pharmacol. 2005 May;67(5):1534-43. doi: 10.1124/mol.104.008532. Epub 2005 Feb 14. Mol Pharmacol. 2005. PMID: 15710745

5

Split peripheral tolerance: CD40 ligation blocks tolerance induction for CD8 T cells but not for CD4 T cells in response to intestinal antigens.

Chung Y, Ko SY, Ko HJ, Kang CY. Chung Y, et al. Among authors: ko sy, ko hj. Eur J Immunol. 2005 May;35(5):1381-90. doi: 10.1002/eji.200425819. Eur J Immunol. 2005. PMID: 15827964 Free article.

6

Optimization of codon usage enhances the immunogenicity of a DNA vaccine encoding mycobacterial antigen Ag85B.

Ko HJ, Ko SY, Kim YJ, Lee EG, Cho SN, Kang CY. Ko HJ, et al. Among authors: ko sy. Infect Immun. 2005 Sep;73(9):5666-74. doi: 10.1128/IAI.73.9.5666-5674.2005. Infect Immun. 2005. PMID: 16113284 Free PMC article.

7

alpha-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor.

Ko SY, Ko HJ, Chang WS, Park SH, Kweon MN, Kang CY. Ko SY, et al. Among authors: ko hj. J Immunol. 2005 Sep 1;175(5):3309-17. doi: 10.4049/jimmunol.175.5.3309. J Immunol. 2005. PMID: 16116223

8

CD1d-restricted T cells license B cells to generate long-lasting cytotoxic antitumor immunity in vivo.

Chung Y, Kim BS, Kim YJ, Ko HJ, Ko SY, Kim DH, Kang CY. Chung Y, et al. Among authors: ko sy, ko hj. Cancer Res. 2006 Jul 1;66(13):6843-50. doi: 10.1158/0008-5472.CAN-06-0889. Cancer Res. 2006. PMID: 16818662

9

A single intranasal immunization with inactivated influenza virus and alpha-galactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system.

Youn HJ, Ko SY, Lee KA, Ko HJ, Lee YS, Fujihashi K, Boyaka PN, Kim SH, Horimoto T, Kweon MN, Kang CY. Youn HJ, et al. Among authors: ko sy, ko hj. Vaccine. 2007 Jul 9;25(28):5189-98. doi: 10.1016/j.vaccine.2007.04.081. Epub 2007 May 21. Vaccine. 2007. PMID: 17548137

10

Mediastinal lymph node CD8alpha- DC initiate antigen presentation following intranasal coadministration of alpha-GalCer.

Ko SY, Lee KA, Youn HJ, Kim YJ, Ko HJ, Heo TH, Kweon MN, Kang CY. Ko SY, et al. Among authors: ko hj. Eur J Immunol. 2007 Aug;37(8):2127-37. doi: 10.1002/eji.200636909. Eur J Immunol. 2007. PMID: 17615581 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

511 results

Search Page

Filters